Phase
Condition
N/ATreatment
Chinese medicine nutritional supplement Cs4
Clinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Male or female patients with age from 18 to 75 years old, who have been previouslydiagnosed with COVID-19 and recovered;
The self-declared post-COVID-19 Functional Status scale should be at least over 1;
The post-COVID symptoms have lasted at least 28 days after diagnosis;
Currently not taking any other orally administered Chinese medicine;
Negative COVID-19 antigen or nucleic acid test within 3 days prior to signing theconsent form;
Voluntary participation in this clinical study.
Exclusion
Exclusion Criteria:
Inability to read and/or write Chinese or English;
Inability to communicate (e.g. with cognitive impairment) 3. Allergy to Cordycepssinensis;
Pregnant or lactating women; 5. Impaired hepatic or renal function.
Study Design
Study Description
Connect with a study center
The School of Chinese Medicine, HKU
Hong Kong, 00000
ChinaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.